Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat

Molecular Brain Research

Volumn 77, Issue 1, 2000, Pages 65-75

  Irving, Elaine A ^a   Barone, Frank C ^a   Reith, Alastair D ^a   Hadingham, Sarah J ^a   Parsons, Andrew A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Ischaemia; Mitogen activated kinase; Oligodendrocytes; p38 MAPK

Indexed keywords

CYTOKINE; GLUTAMIC ACID; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; GLIA; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBRAL CORTEX; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENZYME ACTIVATION; ISCHEMIC ATTACK, TRANSIENT; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROGLIA; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIME FACTORS;

ANIMALIA;

EID: 0034646936     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00043-7     Document Type: Article

References (44)

1. Alessandrini A., Namura S., Moskowitz M.A., Bonventre J.V. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl. Acad. Sci. USA. 96:1999;12866-12869.
2. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD-98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
3. Bading H., Greenberg M.E. Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science. 253:1991;912-914.
4. Barone F.C., Feuerstein G.Z. Inflammatory mediators and stroke: New opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 8:1999;819-834.
5. Barone F.C., Feuerstein G.Z., White R.F., Irving E.A., Parsons A.A., Hadingham S.J., Roberts J., Hunter A.J., Archer G.E., Kumar S., Lee J.C., Smith B.R. Inhibition of p38 mitogen-activated protein kinase reduces brain injury. Neurological deficits and inflammatory cytokines in rat focal stroke. J. Cereb. Blood Flow Metab. 19:(Suppl. 1):1999;613.
6. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePhinho R.A., Panayotatos N., Cobb M.H., Yancopoulos G.D. Erks: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 65:1991;663-675.
7. Butcher S.P., Bullock R., Graham D.I., McCulloch J. Correlation between amino acid release and neuropathologic outcome in rat brain following middles cerebral artery occlusion. Stroke. 21:1990;1727-1733.
8. Cahill M.A., Janknecht R., Nordheim A. Signalling pathways: jack of all cascades. Curr. Biol. 6:1996;16-19.
9. Davis R.J. The mitogen-activated kinase signal transduction pathway. J. Biol. Chem. 268:1993;14553-14556.
10. Deak M., Clifton A.D., Lucocq L.M., Alessi D.R. Mitogen and stress activated protein kinase-1 (MSK1 is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17:1998;4426-4441.
11. Dewar D., Yam P., McCulloch J. Drug development for stroke: importance of protecting cerebral white matter. Eur. J. Pharmacol. 375:1999;41-50.
12. Freshney N., Rawlinson L., Guesdon F., Jones E., Cowley S., Hsuan J., Saklatvala B. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell. 78:1994;1039-1049.
13. Fukunaga R., Hunter T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16:1997;1921-1933.
14. Hara H., Fink K., Endres M., Friedlander R.M., Gagliardini V., Yuan J.Y., Moskowitz M.A. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J. Cereb. Blood Flow Metab. 17:1997;370-375.
15. Hertz L., Peng L., Westergaard N., Yudhoff M., Schousboe A. Neuronal-astrocytic interactions in metabolism of transmitter amino acids of the glutamate family. Schousboe A., Diemer N., Kofod H. Drug Research Related to Neuroactive Amino Acids. 1992;30-50 Mantisgaard, Copenhagen.
16. Horstmann S., Kahle P.J., Borasio G.D. Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro. J. Neurosci. Res. 52:1998;483-490.
17. Janknecht R., Hunter T. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J. 16:1997;1620-1627.
18. Irving E.A., Yatsushiro K., McCulloch J., Dewar D. Rapid alteration of tau in oligodendrocytes after focal ischaemic injury in the rat: involvement of free radicals. J. Cereb. Blood Flow Metab. 17:1997;612-622.
19. Kawaguchi M., Kimbro J.R., Drummond J.C., Cole D.J., Hu B.R., Patel P.M. Effect of map kinase inhibition on spreading depression induced acquisition of ischemic tolerance. J. Cereb. Blood Flow Metab. 19:(Suppl. 1):1999;S705.
20. Kawasaki H., Morooka T., Shimohama S., Kimura J., Hirano T., Gotoh Y., Nishida E. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272:1997;18518-18521.
21. Kobayashi S., Harris V.A., Welsh F.A. Spreading depression induces tolerance of cortical neurons to ischemia in rat brain. J. Cereb. Blood Flow Metab. 15:1995;721-727.
22. Kummer T.L., Rao P.K., Heidenreich K.A. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272:1997;20490-20494.
23. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Green D., McNulty D., Blumenthal M.J., Heys R.J., Landvatter S.W., Strickler J.E., McLaughlin M.M., Siemens I., Fisher S., Livi G.P., White J.R., Adams J.L., Young P.R. Identification and characterization of a novel protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739-746.
24. Ludwig S., Hoffmeyer A., Goebeler M., Kilian K., Häfner H., Neufeld B., Han J., Rapps U.R. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinase 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J. Biol. Chem. 273:1998;1917-1922.
25. Ma X.L., Kumar S., Gao F., Louden C.S., Lopez B.L., Christopher T.A., Wang C., Lee J.C., Feuerstein G.Z., Yue T.L. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation. 61:1999;1685-1691.
26. Mackay K., Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J. Biol. Chem. 274:1999;6272-6279.
27. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase. Proc. Natl. Acad. Sci. USA. 95:1998;11975-11980.
28. Alessandrini A., Cole A.J., Yee A.G., Furshpan E.J. Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc. Natl. Acad. Sci. USA. 95:1998;11975-11980.
29. Namura S., Matsushita K., Alessandrini A., Bonventre J.V., Moskowitz M.A. A MEK-1-specific inhibitor PD98059 attenuates hippocampal injury after global ischemia in the gerbil. J. Cereb. Blood Flow Metab. 19:(Suppl. 1):1999;S159.
30. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., Davis R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:1995;7420-7426.
31. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A.R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 78:1994;1027-1037.
32. Rundén E., Seglen P.O., Haug F.-M., Otterson O.P., Wieloch T., Shamloo M., Laake J.H. Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: Evidence for MAP kinase-dependent mechanism. J. Neurosci. 18:1998;7296-7305.
33. Segal R.A., Greenberg M.E. Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19:1996;463-489.
34. Seger R., Krebs E.G. The MAPK signalling cascade. FASEB J. 9:1995;726-735.
35. Sidotidefraisse C., Rincheval V., Risler Y., Mignotte B., Vayssiere J.L. TNF-alpha activates at least two apoptotic signalling cascades. Oncogene. 17:1998;1639-1651.
36. Skaper S.D., Walsh F.S. Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration. Mol. Cell Neurosci. 12:1998;179-183.
37. Tan Y., Rouse J., Zhang A., Cariati S., Cohen P., Comb M.J. FGF and stress regulated CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 15:1996;4629-4624.
38. Tanaka K., Nagata E., Suzuki S., Dembo T., Nogawa S., Fukuuchi Y. Immunohistochemical analysis of cyclic AMP response element binding protein phosphorylation in focal cerebral ischaemia in rats. Brain Res. 818:1999;520-526.
39. Traverse S., Gomez N., Paterson H., Marshall C.J., Cohen P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288:1992;351-355.
40. Walton K.M., DiRocco R., Bartlett B.A., Koury E., Marcy V.R., Jarvis B., Schaefer E.M., Bhat R.V. Activation of p38 MAPK in microglia after ischemia. J. Neurochem. 70:1998;1764-1767.
41. Walton M., Conner B., Lawlor P., Young D., Sirimanne E., Gluckman P., Cole G., Dragunow M. Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res. Rev. 29:1999;137-168.
42. Whitmarsh A.J., Yang S.H., Su M.S., Sharrocks A.D., Davis R.J. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17:1997;2360-2371.
43. Xing J., Kornhauser J.M., Xia Z., Thiele E.A., Greenberg M.E. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol. Cell. Biol. 18:1998;1946-1955.
44. Zea Longa E.L., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.